|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Denali Therapeutics (NASDAQ: DNLI) through any online brokerage.
There are no as such competitors for Denali Therapeutics.
The latest price target for Denali Therapeutics (NASDAQ: DNLI) was reported by HC Wainwright & Co. on 2021-02-26. The analyst firm set a price target for 95.00 expecting DNLI to rise to within 12 months (a possible 81.78% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $52.26 last updated Fri Apr 09 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Denali Therapeutics.
There is no upcoming split for Denali Therapeutics.